Board of Directors

The Board of Stemina Biomarker Discovery includes industry leaders with the business acumen and good judgment to lead us forward.

Elizabeth L. R. Donley, JD, MBA, MS

Chief Executive Officer

Heiner Dreismann, Ph.D.

Former President & CEO – Roche Molecular Systems; Global Head of Business Development – Roche Diagnostics

Andrew Ferrara

Chairman - Boston HealthCare

Kevin Krenitsky, MD

President - OpGen

R. Andrew Morgan, R.Ph

Executive Vice President Regulatory Affairs & Quality Operations - Zurex Pharma and Zurex PharmAgra

Marc Schneebaum

Senior Vice President and Chief Financial Officer – Madrigal Pharmaceuticals